{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:48:26Z","timestamp":1762004906626,"version":"3.37.3"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T00:00:00Z","timestamp":1500336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0181015","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T17:33:54Z","timestamp":1500399234000},"page":"e0181015","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":33,"title":["MicroRNA 155-deficiency leads to decreased autoantibody levels and reduced severity of nephritis and pneumonitis in pristane-induced lupus"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-2240","authenticated-orcid":true,"given":"Harald","family":"Leiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilhelm","family":"Salzberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Gessl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Kozakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Bl\u00fcml","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Puchner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Attila","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno K.","family":"Podesser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef S.","family":"Smolen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg H.","family":"Stummvoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2017,7,18]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaut.2010.06.018","article-title":"Pathogenetic aspects of systemic lupus erythematosus with an emphasis on regulatory T cells","volume":"35","author":"C Scheinecker","year":"2010","journal-title":"Journal of autoimmunity"},{"key":"ref2","article-title":"The patients\u2018 perspective: Living with Lupus in Austria","author":"G Stummvoll","year":"2017","journal-title":"Wien Klin Wochenschr"},{"issue":"9","key":"ref3","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJMra071297","article-title":"Systemic lupus erythematosus","volume":"358","author":"A Rahman","year":"2008","journal-title":"N Engl J Med"},{"issue":"5","key":"ref4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/art.1780330505","article-title":"Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study","volume":"33","author":"EJ ter Borg","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref5","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus-an update","volume":"24","author":"J Choi","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/1529-0131(200104)44:4<856::AID-ANR142>3.0.CO;2-A","article-title":"Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies","volume":"44","author":"C Scheinecker","year":"2001","journal-title":"Arthritis Rheum-Us"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2004.05.001","article-title":"T cells in the pathogenesis of systemic lupus erythematosus","volume":"113","author":"RW Hoffman","year":"2004","journal-title":"Clin Immunol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/ard.2007.074690","article-title":"Foxp3 expression in CD4+ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis","volume":"67","author":"M Bonelli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13075-015-0538-0","article-title":"Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease","volume":"17","author":"EN Hadaschik","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"ref10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/art.21571","article-title":"The type I interferon system in systemic lupus erythematosus","volume":"54","author":"L Ronnblom","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2353\/ajpath.2006.050125","article-title":"Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane)","volume":"168","author":"DC Nacionales","year":"2006","journal-title":"Am J Pathol"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"L Bennett","year":"2003","journal-title":"J Exp Med"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2249.2009.03880.x","article-title":"Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus","volume":"156","author":"KO Kong","year":"2009","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/1756-185X.12083","article-title":"MicroRNAs in the pathogenesis of systemic lupus erythematosus","volume":"16","author":"X Ma","year":"2013","journal-title":"International journal of rheumatic diseases"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"271694","DOI":"10.1155\/2011\/271694","article-title":"Murine models of systemic lupus erythematosus","volume":"2011","author":"D Perry","year":"2011","journal-title":"J Biomed Biotechnol"},{"issue":"12","key":"ref16","doi-asserted-by":"crossref","first-page":"e14302","DOI":"10.1371\/journal.pone.0014302","article-title":"Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus","volume":"5","author":"R Dai","year":"2010","journal-title":"PLoS One"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/978-1-4939-0326-9_9","article-title":"Induced murine models of systemic lupus erythematosus","volume":"1134","author":"Y Xu","year":"2014","journal-title":"Methods Mol Biol"},{"issue":"9","key":"ref18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.it.2009.06.003","article-title":"Induction of autoimmunity by pristane and other naturally occurring hydrocarbons","volume":"30","author":"WH Reeves","year":"2009","journal-title":"Trends Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s13075-015-0886-9","article-title":"Maintenance of autoantibody production in pristane-induced murine lupus","volume":"17","author":"S Han","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-069X-6-8","article-title":"Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study","volume":"6","author":"J Dahlgren","year":"2007","journal-title":"Environ Health"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"W Filipowicz","year":"2008","journal-title":"Nat Rev Genet"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/art.30281","article-title":"Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice","volume":"63","author":"S Bluml","year":"2011","journal-title":"Arthritis Rheum-Us"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","article-title":"Role of microRNA-155 in autoimmunity","volume":"22","author":"RX Leng","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"ref24","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/ar4131","article-title":"MicroRNA control in the development of systemic autoimmunity","volume":"15","author":"R Hu","year":"2013","journal-title":"Arthritis research & therapy"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.immuni.2010.09.009","article-title":"MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development","volume":"33","author":"RM O'Connell","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"ref26","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.4049\/jimmunol.0803162","article-title":"Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells","volume":"182","author":"S Kohlhaas","year":"2009","journal-title":"J Immunol"},{"issue":"50","key":"ref27","doi-asserted-by":"crossref","first-page":"20194","DOI":"10.1073\/pnas.1317632110","article-title":"Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas(lpr) mouse","volume":"110","author":"TH Thai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.39485","article-title":"In Vivo Therapeutic Success of MicroRNA-155 Antagomir in a Mouse Model of Lupus Alveolar Hemorrhage","volume":"68","author":"S Zhou","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.4049\/jimmunol.1403028","article-title":"miR-155 Deficiency Ameliorates Autoimmune Inflammation of Systemic Lupus Erythematosus by Targeting S1pr1 in Faslpr\/lpr Mice","volume":"194","author":"Q Xin","year":"2015","journal-title":"J Immunol"},{"issue":"8","key":"ref30","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1177\/0961203313492869","article-title":"Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation","volume":"22","author":"H Leiss","year":"2013","journal-title":"Lupus"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cytogfr.2011.05.002","article-title":"Role of microRNA-155 in autoimmunity","volume":"22","author":"RX Leng","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"4","key":"ref32","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.4049\/jimmunol.0802948","article-title":"Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway","volume":"182","author":"N Jacob","year":"2009","journal-title":"J Immunol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/01.ASN.0000108969.21691.5D","article-title":"The classification of glomerulonephritis in systemic lupus erythematosus revisited","volume":"15","author":"JJ Weening","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"AM Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"2","key":"ref35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0002-9440(10)63144-6","article-title":"Repair of local bone erosions and reversal of systemic bone loss upon therapy with anti-tumor necrosis factor in combination with osteoprotegerin or parathyroid hormone in tumor necrosis factor-mediated arthritis","volume":"164","author":"K Redlich","year":"2004","journal-title":"The American journal of pathology"},{"issue":"3","key":"ref36","first-page":"530","article-title":"Sex hormones modulate the response of pulmonary perivascular inflammation to cyclophosphamide therapy in MRL\/MpJ-lpr\/lpr mice","volume":"131","author":"WN McKenzie Jr.","year":"1988","journal-title":"Am J Pathol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-1-59745-401-8_17","article-title":"Bone histomorphometry in arthritis models","volume":"135","author":"G Schett","year":"2007","journal-title":"Methods in molecular medicine"},{"issue":"30","key":"ref38","doi-asserted-by":"crossref","first-page":"10525","DOI":"10.1073\/pnas.0801414105","article-title":"Development of pulmonary fibrosis through a pathway involving the transcription factor Fra-2\/AP-1","volume":"105","author":"R Eferl","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref39","article-title":"Selective CDK4\/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma","author":"JP Leonard","year":"2012","journal-title":"Blood"},{"issue":"5","key":"ref40","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.immuni.2012.03.010","article-title":"12\/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance","volume":"36","author":"S Uderhardt","year":"2012","journal-title":"Immunity"},{"issue":"3","key":"ref41","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.181.3.1908","article-title":"Th1, Th2, and Th17 effector T cell-induced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells","volume":"181","author":"GH Stummvoll","year":"2008","journal-title":"Journal of immunology"},{"issue":"9","key":"ref42","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1093\/rheumatology\/kem117","article-title":"Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus","volume":"46","author":"VR Chowdhary","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"ref43","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.celrep.2012.10.025","article-title":"Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity","volume":"2","author":"TB Huffaker","year":"2012","journal-title":"Cell Rep"},{"issue":"5824","key":"ref44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1126\/science.1139253","article-title":"Requirement of bic\/microRNA-155 for normal immune function","volume":"316","author":"A Rodriguez","year":"2007","journal-title":"Science"},{"issue":"1","key":"ref45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.immuni.2008.11.010","article-title":"Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein","volume":"30","author":"LF Lu","year":"2009","journal-title":"Immunity"},{"issue":"6","key":"ref46","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ni.2576","article-title":"The microRNA miR-155 controls CD8(+) T cell responses by regulating interferon signaling","volume":"14","author":"DT Gracias","year":"2013","journal-title":"Nat Immunol"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1073\/pnas.0610731104","article-title":"MicroRNA-155 is induced during the macrophage inflammatory response","volume":"104","author":"RM O'Connell","year":"2007","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0181015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:44:02Z","timestamp":1589035442000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0181015"}},"subtitle":[],"editor":[{"given":"Masataka","family":"Kuwana","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,7,18]]},"references-count":47,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0181015","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2017,7,18]]}}}